Changquan Ling

Faculty of Traditional Chinese Medicine, Naval Medical University

Research Area

Biography

Changquan Ling has not added Biography.
If you are Changquan Ling and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2026

Other Publications

Article	Year
Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine. Journal of integrative medicine\| PubMed ID: 29891180	2018
Efficacy of complementary and integrative medicine on health-related quality of life in cancer patients: a systematic review and meta-analysis. Cancer management and research\| PubMed ID: 31413628	2019
Sec62 promotes early recurrence of hepatocellular carcinoma through activating integrinα/CAV1 signalling. Oncogenesis\| PubMed ID: 31822656	2019
Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). Journal of integrative medicine\| PubMed ID: 32122812	2020
Comparable effects of Jiedu Granule, a compound Chinese herbal medicine, and sorafenib for advanced hepatocellular carcinoma: A prospective multicenter cohort study. Journal of integrative medicine\| PubMed ID: 32532615	2020
Sleep quality and military training injury during basic combat training: a prospective cohort study of Chinese male recruits. Occupational and environmental medicine\| PubMed ID: 33268467	2020
Preventive Effects of on Heat Stroke in Rats by Sustaining Intestinal Barrier Function and Modulating Gut Microbiota. Frontiers in microbiology\| PubMed ID: 33889138	2021
Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 34547466	2022
Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey. Journal of integrative medicine\| PubMed ID: 34774463	2022
The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment. Frontiers in oncology\| PubMed ID: 34868982	2021
Complementary and alternative medicine during COVID-19 pandemic: What we have done. Journal of integrative medicine\| PubMed ID: 34896048	2022
Neurospora crassa is a potential source of anti-cancer agents against breast cancer. Breast cancer (Tokyo, Japan)\| PubMed ID: 35881300	2022
Opposite effect of basic combat training on mood state of recruits with different physical fitness: A study from perspective of fatigue. Frontiers in psychology\| PubMed ID: 36160583	2022
Valeric acid acts as a novel HDAC3 inhibitor against prostate cancer. Medical oncology (Northwood, London, England)\| PubMed ID: 36175803	2022
Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis. Frontiers in pharmacology\| PubMed ID: 36313291	2022
Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitor. Cancer cell international\| PubMed ID: 36424626	2022
Comprehensive evaluation of military training-induced fatigue among soldiers in China: A Delphi consensus study. Frontiers in public health\| PubMed ID: 36523578	2022
Impact of treatment-duration-ratio of traditional Chinese medicine on survival period of primary liver cancer -A real-world study. Heliyon\| PubMed ID: 36619473	2022
Targeting tumor-derived exosome-mediated premetastatic niche formation: The metastasis-preventive value of traditional Chinese medicine. Cancer letters\| PubMed ID: 37302563	2023
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition. Cancer cell international\| PubMed ID: 37716965	2023
Potential of Dietary HDAC2i in Breast Cancer Patients Receiving PD-1/PD-L1 Inhibitors. Nutrients\| PubMed ID: 37764768	2023
Hypoxia-induced exosomes facilitate lung pre-metastatic niche formation in hepatocellular carcinoma through the miR-4508-RFX1-IL17A-p38 MAPK-NF-κB pathway. International journal of biological sciences\| PubMed ID: 37781522	2023
Sanshimao formula inhibits the hypoxia-induced pro-angiogenesis of hepatocellular carcinoma cells partly through regulating MKK6/p38 signaling pathway. The Journal of pharmacy and pharmacology\| PubMed ID: 38290061	2024
Melittin analog p5RHH enhances recombinant adeno-associated virus transduction efficiency. Journal of integrative medicine\| PubMed ID: 38307819	2024
Oleanolic acid inhibits hypoxic tumor-derived exosomes-induced premetastatic niche formation in hepatocellular carcinoma by targeting ERK1/2-NFκB signaling. Phytomedicine : international journal of phytotherapy and phytopharmacology\| PubMed ID: 38387275	2024
A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma\| PubMed ID: 38496249	2024
Ginsenoside Rh1 regulates the immune microenvironment of hepatocellular carcinoma via the glucocorticoid receptor. Journal of integrative medicine\| PubMed ID: 39455405	2024
Jiedu recipe, a compound Chinese herbal medicine, suppresses hepatocellular carcinoma metastasis by inhibiting the release of tumor-derived exosomes in a hypoxic microenvironment. Journal of integrative medicine\| PubMed ID: 39521704	2024
Hepatitis B Virus Knowledge and HBV-Related Surveillance Status Among HBsAg-Positive Patients in Qidong City: A Rural-Based Cross-Sectional Survey. Healthcare (Basel, Switzerland)\| PubMed ID: 39791624	2024
Paeoniflorin inhibits chronic restraint stress-induced progression of hepatocellular carcinoma through suppressing norepinephrine-induced activation of hepatic stellate cells via SRC/AKT/ERK... Journal of ethnopharmacology\| PubMed ID: 39971013	2025
HDAC3: A Multifaceted Modulator in Immunotherapy Sensitization. Vaccines\| PubMed ID: 40006729	2025
Twenty years of research on exercise-induced fatigue: A bibliometric analysis of hotspots, bursts, and research trends. Medicine\| PubMed ID: 40128028	2025
WITHDRAWN: Integrating serum pharmacochemistry and network pharmacology to explore the potential mechanisms of Xianshen formula in the prevention of exercise-induced fatigue. Fitoterapia\| PubMed ID: 40374150	2025
Unlocking mRNA Vaccine Potential in Liver Cancer Treatment via Synergistic Bile Acid Modulation. Vaccines\| PubMed ID: 40432113	2025
Arsenic Trioxide Enhances the Efficacy of PD-1 Inhibitors in Hepatocellular Carcinoma by Inducing Immunogenic Cell Death via the ROS/ERS Pathway. Immunity, inflammation and disease\| PubMed ID: 40504080	2025
Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged mice. Frontiers in pharmacology\| PubMed ID: 40822466	2025
Performance Assessment of ChatGPT-4.0 and ChatGLM Series in Traditional Chinese Medicine for Metabolic Associated Fatty Liver Disease: Comparative Study. JMIR formative research\| PubMed ID: 40854301	2025
China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition). Liver cancer\| PubMed ID: 41063733	2025
A Core Outcome Set for Clinical Trials on Post COVID-19 Condition: "What," "When," and "How" to Measure. Journal of evidence-based medicine\| PubMed ID: 41273759	2025
A DPAL method for the identification of the synergistic target of drugs. Journal of pharmaceutical analysis\| PubMed ID: 41377139	2025
Pleiotropic mechanisms of cancer-associated fibroblast-mediated resistance in hepatocellular carcinoma: emerging therapeutic vulnerabilities and targeting strategies. Cancer gene therapy\| PubMed ID: 41691133	2026